ReviewMDM policy & practice

Infliximab Pricing in International Economic Evaluations in Inflammatory Bowel Disease to Inform Biologic and Biosimilar Access Policies: A Systematic Review.

Naazish S Bashir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.